Expert commentary on the challenges and opportunities for surgical site infection prevention through implementation of evidence-based guidelines in the Asia-Pacific Region.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
01 04 2021
Historique:
received: 18 11 2020
accepted: 26 02 2021
entrez: 2 4 2021
pubmed: 3 4 2021
medline: 17 12 2021
Statut: epublish

Résumé

Surgical site infections (SSIs) are a significant source of morbidity and mortality in the Asia-Pacific region (APAC), adversely impacting patient quality of life, fiscal productivity and placing a major economic burden on the country's healthcare system. This commentary reports the findings of a two-day meeting that was held in Singapore on July 30-31, 2019, where a series of consensus recommendations were developed by an expert panel composed of infection control, surgical and quality experts from APAC nations in an effort to develop an evidence-based pathway to improving surgical patient outcomes in APAC. The expert panel conducted a literature review targeting four sentinel areas within the APAC region: national and societal guidelines, implementation strategies, postoperative surveillance and clinical outcomes. The panel formulated a series of key questions regarding APAC-specific challenges and opportunities for SSI prevention. The expert panel identified several challenges for mitigating SSIs in APAC; (a) constraints on human resources, (b) lack of adequate policies and procedures, (c) lack of a strong safety culture, (d) limitation in funding resources, (e) environmental and geographic challenges, (f) cultural diversity, (g) poor patient awareness and (h) limitation in self-responsibility. Corrective strategies for guideline implementation in APAC were proposed that included: (a) institutional ownership of infection prevention strategies, (b) perform baseline assessments, (c) review evidence-based practices within the local context, (d) develop a plan for guideline implementation, (e) assess outcome and stakeholder feedback, and (f) ensure long-term sustainability. Reducing the risk of SSIs in APAC region will require: (a) ongoing consultation and collaboration among stakeholders with a high level of clinical staff engagement and (b) a strong institutional and national commitment to alleviate the burden of SSIs by embracing a safety culture and accountability.

Identifiants

pubmed: 33795007
doi: 10.1186/s13756-021-00916-9
pii: 10.1186/s13756-021-00916-9
pmc: PMC8017777
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

65

Références

Clin Infect Dis. 2018 Mar 5;66(6):970-976
pubmed: 29514241
Infect Control Hosp Epidemiol. 2014 Jun;35(6):660-6
pubmed: 24799642
Antimicrob Resist Infect Control. 2017 Apr 8;6:35
pubmed: 28405312
JAMA Surg. 2017 Jul 1;152(7):686-690
pubmed: 28403477
Infect Control Hosp Epidemiol. 2015 Oct;36(10):1208-14
pubmed: 26198467
J Gastrointest Surg. 2017 Nov;21(11):1915-1930
pubmed: 28620749
World J Emerg Surg. 2018 Aug 17;13:37
pubmed: 30140304
JAMA Surg. 2014 Oct;149(10):1045-52
pubmed: 25163027
J Ayub Med Coll Abbottabad. 2017 Oct-Dec;29(4):580-586
pubmed: 29330982
Br J Surg. 2014 Feb;101(3):150-8
pubmed: 24469615
Infect Control Hosp Epidemiol. 2016 Oct;37(10):1167-72
pubmed: 27430979
Ann Surg Oncol. 2017 Feb;24(2):362-368
pubmed: 27573526
J Infect Prev. 2019 Jan;20(1):5-17
pubmed: 30719083
Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604
pubmed: 23651890
Molecules. 2017 Sep 19;22(9):
pubmed: 28925959
Infect Control Hosp Epidemiol. 2020 Feb;41(2):194-201
pubmed: 31884977
Br J Surg. 2017 Jan;104(2):e41-e54
pubmed: 28121039
BMJ Qual Saf. 2011 Jan;20(1):102-7
pubmed: 21228082
Surgery. 2014 Apr;155(4):602-6
pubmed: 24468041
Clin Infect Dis. 2017 May 15;64(suppl_2):S61-S67
pubmed: 28475790
J Telemed Telecare. 2017 Feb;23(2):321-327
pubmed: 27056907
Antimicrob Agents Chemother. 2011 Oct;55(10):4659-63
pubmed: 21825293
Microorganisms. 2017 Apr 01;5(2):
pubmed: 28368320
Clin Infect Dis. 2015 Jun 1;60(11):1690-9
pubmed: 25676799
J Infect Dev Ctries. 2015 Feb 19;9(2):182-9
pubmed: 25699493
Infect Control Hosp Epidemiol. 2011 Feb;32(2):101-14
pubmed: 21460463
Int J Infect Dis. 2019 Mar;80:34-45
pubmed: 30639405
J Korean Surg Soc. 2011 Nov;81(5):295-307
pubmed: 22148121
Infect Control Hosp Epidemiol. 2019 Mar;40(3):287-300
pubmed: 30786946
Healthc Exec. 2015 Mar-Apr;30(2):18-20, 22-4, 26
pubmed: 26738274
J Epidemiol. 2012;22(2):86-90
pubmed: 22307433
Am J Infect Control. 2010 May;38(4):264-73
pubmed: 20116133
Spine (Phila Pa 1976). 2018 Dec 15;43(24):1765-1773
pubmed: 29794586
J Craniofac Surg. 2017 Sep;28(6):1408-1412
pubmed: 28692506
Int Wound J. 2015 Jun;12(3):357-62
pubmed: 24612792
Surgery. 2015 Jul;158(1):66-77
pubmed: 25920911
Curr Treat Options Infect Dis. 2020 Mar 19;:1-10
pubmed: 32218708
JAMA Surg. 2019 Feb 1;154(2):117-124
pubmed: 30422236
Antimicrob Resist Infect Control. 2019 Jul 15;8:114
pubmed: 31338161
World J Surg. 2017 Dec;41(12):3012-3024
pubmed: 29038828
J Am Acad Orthop Surg. 2020 Jun 1;28(11):e487-e492
pubmed: 32459409
J Surg Res. 2019 Aug;240:206-218
pubmed: 30986636
Am J Infect Control. 2019 May;47(5):540-544
pubmed: 30554880
Infect Control Hosp Epidemiol. 2015 Apr;36(4):409-16
pubmed: 25782895
J Urol. 2018 Feb;199(2):355-369
pubmed: 28655529
Int J Health Plann Manage. 2018 Oct;33(4):836-846
pubmed: 29675898
J Wound Care. 2018 Mar 2;27(3):128-135
pubmed: 29509108
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2381-8
pubmed: 24820192
Br J Anaesth. 2018 Jan;120(1):146-155
pubmed: 29397122
Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1923-1929
pubmed: 30097753
BMC Infect Dis. 2019 May 14;19(1):411
pubmed: 31088389
Antimicrob Resist Infect Control. 2017 May 12;6:45
pubmed: 28507731
Ann Med Surg (Lond). 2014 Aug 07;3(3):85-91
pubmed: 25568794
Clin Epidemiol. 2009 Aug 09;1:67-74
pubmed: 20865088
J Gastrointest Surg. 2015 May;19(5):935-42
pubmed: 25691114
Surg Infect (Larchmt). 2018 Apr;19(3):313-320
pubmed: 29480742
JAMA Surg. 2017 Aug 1;152(8):784-791
pubmed: 28467526
Lancet Infect Dis. 2018 May;18(5):516-525
pubmed: 29452941
PLoS One. 2017 Sep 6;12(9):e0184200
pubmed: 28877223
Surg Infect (Larchmt). 2016 Apr;17(2):256-61
pubmed: 26891203
Dis Colon Rectum. 2018 Jan;61(1):89-98
pubmed: 29215475

Auteurs

K Morikane (K)

Division of Clinical Laboratory and Infection Control, Yamagata University Hospital, Yamagata, Japan.

P L Russo (PL)

School of Nursing and Midwifery, Monash University, Frankston, VC, Australia.

K Y Lee (KY)

Department of Surgery, KyungHee University Medical Center, Seoul, South Korea.

M Chakravarthy (M)

Fortis Healthcare Limited, Gurgaon, Haryana, India.

M L Ling (ML)

Infection Prevention and Epidemiology, Singapore General Hospital, Singapore, Singapore.

E Saguil (E)

Philippine General Hospital, Manila, Philippines.

M Spencer (M)

Infection Prevention Consultant, Boston, MA, USA.

W Danker (W)

Ethicon, Johnson and Johnson Medical Device Companies, Somerville, NJ, USA.

A Seno (A)

Johnson and Johnson Medical Asia Pacific, Singapore, Singapore.

E Edmiston Charles (EE)

Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA. edmiston@mcw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH